| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
3,145 |
2,582 |
$718.83 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
1,928 |
1,566 |
$210.52 |
| 83036 |
Hemoglobin; glycosylated (A1C) |
2,654 |
2,625 |
$0.00 |
| 85027 |
|
240 |
231 |
$0.00 |
| 80053 |
Comprehensive metabolic panel |
2,923 |
2,800 |
$0.00 |
| 36415 |
Collection of venous blood by venipuncture |
4,662 |
4,262 |
$0.00 |
| 1111F |
|
241 |
210 |
$0.00 |
| 82043 |
|
460 |
460 |
$0.00 |
| 3075F |
|
248 |
238 |
$0.00 |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
91 |
90 |
$0.00 |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
270 |
266 |
$0.00 |
| 3079F |
|
263 |
242 |
$0.00 |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
445 |
429 |
$0.00 |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
1,584 |
1,492 |
$0.00 |
| 84443 |
Thyroid stimulating hormone (TSH) |
103 |
98 |
$0.00 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
367 |
358 |
$0.00 |
| 86780 |
|
193 |
192 |
$0.00 |
| 99441 |
|
319 |
310 |
$0.00 |
| 99443 |
|
147 |
145 |
$0.00 |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
359 |
355 |
$0.00 |
| 1220F |
|
408 |
405 |
$0.00 |
| 92227 |
|
13 |
13 |
$0.00 |
| 3074F |
|
710 |
629 |
$0.00 |
| 90656 |
|
55 |
55 |
$0.00 |
| 87522 |
Neg quan hep c or qual rna |
62 |
62 |
$0.00 |
| 4450F |
|
285 |
281 |
$0.00 |
| 3044F |
|
385 |
381 |
$0.00 |
| 81001 |
|
13 |
13 |
$0.00 |
| 90686 |
|
25 |
25 |
$0.00 |
| 3080F |
|
15 |
14 |
$0.00 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
12 |
12 |
$0.00 |
| 90674 |
|
17 |
17 |
$0.00 |
| U0005 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 |
17 |
17 |
$0.00 |
| 86703 |
|
444 |
442 |
$0.00 |
| 82540 |
|
460 |
460 |
$0.00 |
| 80061 |
Lipid panel |
2,415 |
2,396 |
$0.00 |
| 99442 |
|
880 |
849 |
$0.00 |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
891 |
866 |
$0.00 |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
270 |
266 |
$0.00 |
| 82274 |
|
332 |
332 |
$0.00 |
| 3077F |
|
271 |
256 |
$0.00 |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
332 |
175 |
$0.00 |
| 80074 |
|
42 |
42 |
$0.00 |
| 3078F |
|
892 |
796 |
$0.00 |
| 90750 |
|
13 |
13 |
$0.00 |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
25 |
25 |
$0.00 |
| 85610 |
|
28 |
24 |
$0.00 |
| 91300 |
|
13 |
13 |
$0.00 |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
27 |
27 |
$0.00 |
| 84439 |
|
12 |
12 |
$0.00 |
| 86480 |
|
12 |
12 |
$0.00 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
18 |
18 |
$0.00 |
| 77062 |
|
25 |
25 |
$0.00 |